Stay updated on M7824 and Topotecan in Relapsed SCLC Clinical Trial
Sign up to get notified when there's something new on the M7824 and Topotecan in Relapsed SCLC Clinical Trial page.

Latest updates to the M7824 and Topotecan in Relapsed SCLC Clinical Trial page
- Check3 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content with an access-denied screen. This prevents viewing the NCT03554473 study details and related navigation on ClinicalTrials.gov.SummaryDifference25%

- Check10 days agoChange DetectedRevision updated from v3.6.6 to v3.7.0, indicating a maintenance release of the page. This change seems to affect the underlying platform or user interface rather than the study details.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe study page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This appears to be an administrative update to the record that does not change the study content.SummaryDifference0.0%

- Check45 days agoChange DetectedThe site revision label updated from v3.6.4 to v3.6.5, signaling a new deployment of the platform. There is no indication that the content of the study page was changed.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page revision label changed from v3.6.3 to v3.6.4. This reflects a deployment or maintenance update and does not alter the displayed content.SummaryDifference0.0%

- Check88 days agoChange DetectedThe page revision was updated to v3.6.3, reflecting a new release of the page's UI/content. The study information displayed remains unchanged.SummaryDifference0.0%

Stay in the know with updates to M7824 and Topotecan in Relapsed SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M7824 and Topotecan in Relapsed SCLC Clinical Trial page.